Safety, Tolerability, and Efficacy of Deferasirox in MDS

Clinical trial NCT00469560 · COMPLETED

Trial details

NCT number: NCT00469560
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Hemosiderosis

Start date: 2007-06-01
Primary completion: 2010-03-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.